Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.

A physiologically based pharmacokinetic model for digoxin disposition developed in the rat was modified to account for the interspecies differences in tissue-to-plasma digoxin concentration ratios and applied to the dog. The model provided a quantitative assessment of the time course of digoxin concentrations in dog plasma, various tissues, and urine. It also predicted the effect of renal failure on digoxin pharmacokinetics in the dog. An attempt to scale the dog model to humans by simply considering differences in organ volumes, organ flow rates, and digoxin clearances was partially successful. Good predictions of plasma digoxin concentration and urinary digoxin excretion after a single dose and of steady-state plasma, heart, and skeletal muscle digoxin concentrations were obtained. However, the model predicted considerably higher kidney digoxin concentrations than are actually found. Although the model adequately characterized the time course of digoxin concentrations in patients with moderate renal impairment, it provided a relatively poor fit to that observed in anuric patients.

[1]  M. O'Rourke,et al.  Digoxin concentrations in the serum and myocardium of digitalised patients. , 1973, Australian and New Zealand journal of medicine.

[2]  C. Klaassen,et al.  Biliary excretion of cardiac glycosides. , 1973, The Journal of pharmacology and experimental therapeutics.

[3]  B. Johnson,et al.  Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration. , 1975, British heart journal.

[4]  D. Greenblatt,et al.  Intravenous digoxin as a bioavailability standard: Slow infusion and rapid injection , 1974, Clinical pharmacology and therapeutics.

[5]  D. Harrison,et al.  Correlation of Serum Concentrations with Heart Concentrations of Digoxin in Human Subjects , 1974, Circulation.

[6]  J. Doherty,et al.  Tissue concentration and turnover of tritiated digoxin in dogs. , 1966, The American journal of cardiology.

[7]  W. Jusko,et al.  Digoxin pharmacokinetics: Role of renal failure in dosage regimen design , 1975, Clinical pharmacology and therapeutics.

[8]  P. Ongley,et al.  The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H. , 1966, The Journal of laboratory and clinical medicine.

[9]  E. Adolph,et al.  Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.

[10]  J. Cannon,et al.  Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species. , 1973, Biochemical pharmacology.

[11]  J. Doherty,et al.  Tritiated Digoxin: XIV. Enterohepatic Circulation, Absorption, and Excretion Studies in Human Volunteers , 1970, Circulation.

[12]  N. Benowitz,et al.  Lidocaine disposition kinetics in monkey and man; I. Prediction by a perfusion model , 1974, Clinical pharmacology and therapeutics.

[13]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[14]  H. Halkin,et al.  Determinants of the renal clearance of digoxin , 1975, Clinical pharmacology and therapeutics.

[15]  Å. Bertler,et al.  POST‐MORTEM DISTRIBUTION AND TISSUE CONCENTRATIONS OF DIGOXIN IN INFANTS AND ADULTS , 1975, Acta paediatrica Scandinavica.

[16]  J. Doherty,et al.  Studies with tritiated digoxin in human subjects after intravenous administration. , 1962, American heart journal.

[17]  D. Azarnoff,et al.  Absorption of orally given digoxin preparations. , 1972, JAMA.

[18]  A. Russell,et al.  Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications. , 1976, British journal of clinical pharmacology.

[19]  W W MAPLESON,et al.  An electric analogue for uptake and exchange of inert gases and other agents. , 1963, Journal of applied physiology.

[20]  W. Nelp,et al.  RELATIONSHIP OF THE EXCRETION OF TRITIATED DIGOXIN TO RENAL FUNCTION , 1966, The American journal of the medical sciences.

[21]  R. Rutherford,et al.  Distribution of cardiac output in experimental hemorrhagic shock in dogs. , 1969, Journal of applied physiology.

[22]  G. Bounous,et al.  REGIONAL BLOOD FLOW AND OXYGEN CONSUMPTION IN EXPERIMENTAL HEMORRHAGIC SHOCK. , 1963, Archives of surgery.

[23]  E. Layne,et al.  Studies on tritum-labeled digoxin: tissue, blood and urine determinations. , 1960, The Journal of clinical investigation.

[24]  V. Manninen,et al.  Human serum and myocardium digoxin , 1976, Clinical pharmacology and therapeutics.

[25]  Eve Is,et al.  A review of the physiology of the gastrointestinal tract in relation to radiation doses from radioactive materials. , 1966 .

[26]  M. Gibaldi,et al.  Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. , 1977, Journal of pharmaceutical sciences.

[27]  W. J. Westlake,et al.  Problems associated with analysis of pharmacokinetic models. , 1971, Journal of pharmaceutical sciences.

[28]  F. Marcus,et al.  THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS. , 1964, The Journal of pharmacology and experimental therapeutics.

[29]  R P Forsyth,et al.  Lidocaine disposition kinetics in monkey and man; II. Effects of hemorrhage and sympathomimetic drug administration , 1974, Clinical pharmacology and therapeutics.

[30]  F. Marcus,et al.  The effect of reserpine on the metabolism of tritiated digoxin in the dog and in man. , 1968, The Journal of pharmacology and experimental therapeutics.

[31]  F. Marcus,et al.  The effect of acute hypokalemia on the myocardial concentration and body distribution of tritiated digoxin in the dog. , 1971, The Journal of pharmacology and experimental therapeutics.

[32]  W. Jusko,et al.  Myocardial distribution of digoxin and renal function , 1974, Clinical pharmacology and therapeutics.

[33]  K. Wakim,et al.  Inhibition of Binding of Tritiated Digoxin to Myocardium by Sodium Depletion in Dogs , 1969, Circulation research.

[34]  D. Chamberlain,et al.  Myocardial and Skeletal Muscle Concentrations of Digoxin in Patients on Long-term Therapy , 1972, British medical journal.